Takeda News
Most Popular Takeda Story
FDA throws up roadblock for Takeda's diabetes drug
Takeda confirmed today that the FDA won't approve its critically important diabetes drug alogliptin without a new clinical trial that fully explores the drug's cardiovascular effects. A spokesman for... Read more...
Latest Headlines
- June 29, 2009
- June 5, 2009
- May 18, 2009
- March 31, 2009
- March 9, 2009
- February 20, 2009
- February 17, 2009
- February 10, 2009
- December 24, 2008
- December 3, 2008
- November 25, 2008
- October 16, 2008
- October 10, 2008
- September 26, 2008
- August 29, 2008
- July 23, 2008
- July 23, 2008
- June 9, 2008
- May 27, 2008
- April 25, 2008
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
